Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Sri Krishna Pharmaceuticals Limited
FDA Inspection
•Sri Krishna Pharmaceuticals Limited•May 19, 2023

Sri Krishna Pharmaceuticals Limited – FDA Inspection, May 19, 2023

Record Details

This FDA Inspection record concerns Sri Krishna Pharmaceuticals Limited, with an inspection on May 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Sri Krishna Pharmaceuticals Limited
Inspection Date
May 19, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Arsen Karapetyan
  • Justin A. Boyd (Investigator)
View Company Profile

ID · c00c65b4-1cec-4f8b-9bdf-35d0fbd1b46a

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1206168
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

16
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.58Buildings not maintained in good state of repair
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.198(a)Complaint Handling Procedure
  5. 21 CFR 211.186(a)Master production and control records, procedure
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.22(d)Procedures not in writing, fully followed
  8. 21 CFR 211.100(a)Absence of Written Procedures
  9. 21 CFR 211.100(a)Absence of Written Procedures
  10. 21 CFR 211.186(a)Master production and control records, procedure

Showing 10 of 16 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Sri Krishna Pharmaceuticals Limited

3
DateClassificationOfficeProject area
June 27, 2025OAIOffice of Inspections and InvestigationsDrug Quality Assurance
December 4, 2014OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 23, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Sri Krishna Pharmaceuticals Limited
  • FDA Inspection 1273929 - 2025-06-27
  • FDA Inspection 913677 - 2014-12-04
  • FDA Inspection 757337 - 2011-11-23

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sri Krishna Pharmaceuticals Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.